More information: David Requena et al, Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma, Nature Communications (2024).

Clinical and pathologic features of 23 patients with a distinctive histologic and clinical variant of hepatocellular carcinoma are summarized. The variant pattern of hepatocellular carcinoma is ...

Reference: Requena D, Medico JA, Soto-Ugaldi LF, et al. Liver cancer multiomics reveals diverse protein kinase A disruptions convergently produce fibrolamellar hepatocellular carcinoma. Nat Commun.

Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC ... Moreover, drug therapies for common liver cancers are not just useless for FLC patients but actually harmful.

Long classified as a subset of common liver cancer ... Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few -- in this case ...